SCHEMBL30393035

SCHEMBL30393035

CNc1cc(Nc2cccn(-c3ccc(C(=O)O)cn3)c2=O)nn2c(C(=O)N[C@@H]3C[C@@H]3F)cnc12

nearest known ligand 0.83

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ TYK2 P29597 20/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16812401 1.00 TYK2 (0.83) TYK2
SCHEMBL26101540 0.93 TYK2 (0.82) TYK2
SCHEMBL16812338 0.92 TYK2 (0.80) TYK2
SCHEMBL26101248 0.90 TYK2 (0.81) TYK2
SCHEMBL26100154 0.90 TYK2 (0.81) TYK2
SCHEMBL16812447 0.90 TYK2 (0.76) TYK2
SCHEMBL26101149 0.89 TYK2 (0.82) TYK2
SCHEMBL26101688 0.89 TYK2 (0.79) TYK2
SCHEMBL16812376 0.89 TYK2 (1.00) TYK2
SCHEMBL18143581 0.89 TYK2 (1.00) TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119013277-A TYK2 degrading agent and application thereof 凯麦拉医疗公司 2024-11-22 — — CN disclosed
EP-4423086-A1 TYK2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-09-04 — — EP disclosed
WO-2023076161-A1 TYK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-05-04 — — WO disclosed
Send feedback